ARCHIVES

Study: CYP2D6 Genotypes Are Unreliable Predictors of Benefit

This article is from The Cancer Letter archive.

Vol. 35 No. 3 | March 30, 2012

Download PDF Visit The Full Archive

Related Articles

Generic Drug Makers Set Sights In Taxol Worldwide Market

April 2, 1993

FDA, Clinical Investigators Head Or Showdown Over Demand To See Individual Patient Records

April 18, 1980

President’s Surgery Stirs Interest In Colon Cancer Exams

July 26, 1985

Obituary: Michael Potter, 89, NIH Researcher

June 26, 2013

Kushner Forms BreastPac

June 17, 1988

NCA Approves Major Revision In Program Project Guidelines; Smaller, Tightly Focused Grants Seen

May 27, 1983